WALLAC OY GSP Neonatal GALT Kit recall — FDA Z-2713-2026
Reduction in the on-board stability of the GSP GALT assay. This may increase the likelihood of run-QC failures and consequently delay the reporting of patient results.
Overview of recall records associated with WALLAC OY, including dates, categories and classifications where available.
Classification mix: Class II: 1.
Reduction in the on-board stability of the GSP GALT assay. This may increase the likelihood of run-QC failures and consequently delay the reporting of patient results.
This page summarizes recall records in which the official source identifies WALLAC OY as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.